{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:methylphenidate-hydrochloride-tablet-extended-release",
  "slug": "methylphenidate-hydrochloride-tablet-extended-release",
  "title": "FDA shortage status: Methylphenidate Hydrochloride Tablet, Extended Release",
  "ingredient": "Methylphenidate Hydrochloride Tablet, Extended Release",
  "status": "current",
  "source_statuses": [
    "Current"
  ],
  "brand_names": [
    "CONCERTA",
    "METHYLPHENIDATE HYDROCHLORIDE",
    "RELEXXII"
  ],
  "therapeutic_categories": [
    "Psychiatry"
  ],
  "dosage_forms": [
    "Tablet"
  ],
  "routes": [
    "ORAL"
  ],
  "package_count": 34,
  "packages": [
    {
      "package_ndc": "50458-585-01",
      "product_ndc": "50458-585",
      "company_name": "Janssen Pharmaceuticals",
      "manufacturer_name": "Janssen Pharmaceuticals, Inc.",
      "presentation": "Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/19/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "50458-588-01",
      "product_ndc": "50458-585",
      "company_name": "Janssen Pharmaceuticals",
      "manufacturer_name": "Janssen Pharmaceuticals, Inc.",
      "presentation": "Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/19/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "50458-586-01",
      "product_ndc": "50458-585",
      "company_name": "Janssen Pharmaceuticals",
      "manufacturer_name": "Janssen Pharmaceuticals, Inc.",
      "presentation": "Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/19/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "50458-587-01",
      "product_ndc": "50458-585",
      "company_name": "Janssen Pharmaceuticals",
      "manufacturer_name": "Janssen Pharmaceuticals, Inc.",
      "presentation": "Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/19/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62175-310-37",
      "product_ndc": "62175-310",
      "company_name": "Lannett Company, Inc.",
      "manufacturer_name": "Lannett Company, Inc.",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62175-311-37",
      "product_ndc": "62175-310",
      "company_name": "Lannett Company, Inc.",
      "manufacturer_name": "Lannett Company, Inc.",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62175-312-37",
      "product_ndc": "62175-310",
      "company_name": "Lannett Company, Inc.",
      "manufacturer_name": "Lannett Company, Inc.",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62175-313-37",
      "product_ndc": "62175-310",
      "company_name": "Lannett Company, Inc.",
      "manufacturer_name": "Lannett Company, Inc.",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-606-88",
      "product_ndc": null,
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": null,
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)",
      "availability": "Unavailable",
      "dosage_form": "Tablet",
      "routes": [],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-607-88",
      "product_ndc": null,
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": null,
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)",
      "availability": "Unavailable",
      "dosage_form": "Tablet",
      "routes": [],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-608-88",
      "product_ndc": null,
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": null,
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)",
      "availability": "Unavailable",
      "dosage_form": "Tablet",
      "routes": [],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "57664-609-88",
      "product_ndc": null,
      "company_name": "Sun Pharmaceutical Industries, Inc.",
      "manufacturer_name": null,
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)",
      "availability": "Unavailable",
      "dosage_form": "Tablet",
      "routes": [],
      "update_date": "08/05/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62037-725-01",
      "product_ndc": "62037-725",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Actavis Pharma, Inc.",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62037-734-01",
      "product_ndc": "62037-725",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Actavis Pharma, Inc.",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62037-726-01",
      "product_ndc": "62037-725",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Actavis Pharma, Inc.",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "62037-727-01",
      "product_ndc": "62037-725",
      "company_name": "Teva Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Actavis Pharma, Inc.",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "13811-706-10",
      "product_ndc": "13811-706",
      "company_name": "Trigen Laboratories, LLC",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "13811-707-10",
      "product_ndc": "13811-706",
      "company_name": "Trigen Laboratories, LLC",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "13811-708-10",
      "product_ndc": "13811-706",
      "company_name": "Trigen Laboratories, LLC",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "13811-711-30",
      "product_ndc": "13811-700",
      "company_name": "Trigen Laboratories, LLC",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "13811-709-10",
      "product_ndc": "13811-706",
      "company_name": "Trigen Laboratories, LLC",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "13811-700-30",
      "product_ndc": "13811-700",
      "company_name": "Trigen Laboratories, LLC",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "13811-710-30",
      "product_ndc": "13811-706",
      "company_name": "Trigen Laboratories, LLC",
      "manufacturer_name": "Trigen Laboratories, LLC",
      "presentation": "Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)",
      "availability": "Limited Availability",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-095-10",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-095-30",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-096-10",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-096-30",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-097-10",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-097-30",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-088-30",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-098-10",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-098-30",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-089-30",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "68025-084-30",
      "product_ndc": "68025-084",
      "company_name": "Vertical Pharmaceuticals, LLC",
      "manufacturer_name": "Vertical Pharmaceuticals, LLC",
      "presentation": "Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)",
      "availability": "Available",
      "dosage_form": "Tablet",
      "routes": [
        "ORAL"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "07/26/2023",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 20,
    "Limited Availability": 10,
    "Unavailable": 4
  },
  "initial_posting_date": "07/26/2023",
  "latest_source_update": "08/19/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}